Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group Corporation Limited, has announced amendments to its Articles of Association. These changes are in response to the updated Company Law of the People’s Republic of China and the revised guidelines from the China Securities Regulatory Commission. The company proposes to abolish its Supervisory Committee and transfer its functions to the Audit Committee, aligning with new regulatory requirements and addressing its management needs.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Learn more about 2TZ stock on TipRanks’ Stock Analysis page.